Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Michael Jon Brown net worth and biography

Michael Brown Biography and Net Worth

EVP of DexCom

Michael Brown is Executive Vice President and Chief Legal Officer at Dexcom, where he has worldwide responsibility for all legal and intellectual property matters.

Before joining Dexcom in 2022, Michael was a partner at DLA Piper, where he served as outside general counsel to companies, advised on important business and legal issues, assisted with corporate governance and executed mergers and acquisitions and financings. Prior to that, he was a partner at Stradling Yocca Carlson & Rauth, where he represented emerging and public technology, life science and other growth companies. Before that, Michael served as outside General Counsel for several high-growth companies.

Michael earned his J.D. from the University of Virginia School of Law and his B.A. from the University of Washington. Michael is a board member of Riding on Insulin, a non-profit organization that connects the global diabetes community through action sports.

What is Michael Jon Brown's net worth?: The estimated net worth of Michael Jon Brown is at least $9.47 million as of March 28th, 2024. Mr. Brown owns 68,682 shares of DexCom stock worth more than $9,469,187 as of April 25th. This net worth approximation does not reflect any other assets that Mr. Brown may own. Additionally, Mr. Brown receives a salary of $954,460.00 as EVP at DexCom. Learn More about Michael Jon Brown's net worth.
How old is Michael Jon Brown?: Mr. Brown is currently 54 years old. There are 7 older executives and no younger executives at DexCom. The oldest executive at DexCom is Mr. Kevin Ronald Sayer, Executive Chairman, CEO & President, who is 66 years old. Learn More on Michael Jon Brown's age.
What is Michael Jon Brown's salary?: As the EVP of DexCom, Inc., Mr. Brown earns $954,460.00 per year. There are 2 executives that earn more than Mr. Brown. The highest earning executive at DexCom is Mr. Kevin Ronald Sayer, Executive Chairman, CEO & President, who commands a salary of $2,220,000.00 per year. Learn More on Michael Jon Brown's salary.
How do I contact Michael Jon Brown?: The corporate mailing address for Mr. Brown and other DexCom executives is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. DexCom can also be reached via phone at (858) 200-0200 and via email at [email protected]. Learn More on Michael Jon Brown's contact information.
Has Michael Jon Brown been buying or selling shares of DexCom?: Michael Jon Brown has not been actively trading shares of DexCom during the last quarter. Most recently, Michael Jon Brown sold 2,624 shares of the business's stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $140.04, for a transaction totalling $367,464.96. Following the completion of the sale, the executive vice president now directly owns 68,682 shares of the company's stock, valued at $9,618,227.28. Learn More on Michael Jon Brown's trading history.
Who are DexCom's active insiders?: DexCom's insider roster includes Donald Abbey (EVP), Steven Altman (Director), Nicholas Augustinos (Director), Andrew Balo (Insider), Quentin Blackford (COO), Michael Brown (EVP), Richard Collins (Director), Matthew Dolan (SVP), Richard Doubleday (EVP), Paul Flynn (EVP), Mark Foletta (Director), Bridgette Heller (Director), Barbara Kahn (Director), Jacob Leach (EVP), Jeffrey Moy (EVP), Patrick Murphy (EVP), Steven Pacelli (Insider), Chad Patterson (EVP), Barry Regan (EVP), Kevin Sayer (CEO), Shelly Selvaraj (SVP), Sumi Shrishrimal (SVP), Jay Skyler (Director), Sadie Stern (EVP), and Jereme Sylvain (CAO). Learn More on DexCom's active insiders.
Are insiders buying or selling shares of DexCom?: During the last twelve months, insiders at the medical device company sold shares 40 times. They sold a total of 272,608 shares worth more than $35,590,010.39. The most recent insider tranaction occured on April, 15th when EVP Matthew Vincent Dolan sold 1,990 shares worth more than $274,241.90. Insiders at DexCom own 0.4% of the company. Learn More about insider trades at DexCom.
Information on this page was last updated on 4/15/2024.

Michael Jon Brown Insider Trading History at DexCom

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/28/2024	Sell	2,624	$140.04	$367,464.96	68,682
12/1/2023	Sell	3,612	$114.56	$413,790.72	58,394
4/3/2023	Sell	3,612	$114.48	$413,501.76	61,870

Michael Jon Brown Buying and Selling Activity at DexCom

DexCom Company Overview

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Today's Range

Now: $138.01

$134.45

$139.24

50 Day Range

MA: $130.58

$114.22

$140.45

2 Week Range

Now: $138.01

$74.75

$142.00

Volume

4,164,124 shs

Average Volume

2,976,416 shs

Market Capitalization

$54.66 billion

P/E Ratio

105.35

Dividend Yield

N/A

Beta

1.2

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now

Michael Brown Biography and Net Worth

What is Michael Jon Brown's net worth?

How old is Michael Jon Brown?

What is Michael Jon Brown's salary?

How do I contact Michael Jon Brown?

Has Michael Jon Brown been buying or selling shares of DexCom?

Who are DexCom's active insiders?

Are insiders buying or selling shares of DexCom?